Advertisement
Screener

Quest Diagnostics Inc (DGX) Current State and Local Tax Expense (Benefit)

1.9 / 5 stars · 46/120 Roast Me

Quest Diagnostics Inc Current State and Local Tax Expense (Benefit)

Quest Diagnostics Inc (DGX) reported Current State and Local Tax Expense (Benefit) of $33.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentStateAndLocalTaxExpenseBenefit · last filed 2026-02-26

  • Quest Diagnostics Inc current state and local tax expense (benefit) for fiscal 2025 was $33.00M, a 36.54% decline from fiscal 2024.
  • Quest Diagnostics Inc current state and local tax expense (benefit) for fiscal 2024 was $52.00M, a 11.86% decline from fiscal 2023.
  • Quest Diagnostics Inc current state and local tax expense (benefit) for fiscal 2023 was $59.00M, a 4.84% decline from fiscal 2022.
  • Quest Diagnostics Inc current state and local tax expense (benefit) for fiscal 2022 was $62.00M, a 49.59% decline from fiscal 2021.
Period endCurrent State and Local Tax Expense (Benefit) 12 monthCurrent State and Local Tax Expense (Benefit) 12 month as first filed
2025-12-31$33.00M
10-K · filed 2026-02-26
2024-12-31$52.00M
10-K · filed 2026-02-26
2023-12-31$59.00M
10-K · filed 2026-02-26
2022-12-31$62.00M
10-K · filed 2025-02-20
2021-12-31$123.00M
10-K · filed 2024-02-22
2020-12-31$74.00M
10-K · filed 2023-02-21
2019-12-31$53.00M
10-K · filed 2022-02-28
2018-12-31$26.00M
10-K · filed 2021-02-22
2017-12-31$5.00M
10-K · filed 2020-02-20
2016-12-31$45.00M
10-K · filed 2019-02-21
2015-12-31$27.00M
10-K · filed 2018-02-23
2014-12-31$34.00M
10-K · filed 2017-02-22
2013-12-31$59.00M
10-K · filed 2016-02-26
2012-12-31$61.00M
10-K · filed 2015-02-24
$60.71M
10-K · filed 2013-02-27
2011-12-31$60.00M
10-K · filed 2014-02-18
$60.37M
10-K · filed 2012-02-16
2010-12-31$93.23M
10-K · filed 2013-02-27
$93.37M
10-K · filed 2011-02-16
2009-12-31$81.29M
10-K · filed 2012-02-16
2008-12-31$57.75M
10-K · filed 2011-02-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
LABCORP HOLDINGS INC. (LH)United States$25.060B22.60
Guardant Health, Inc. (GH)United States$23.675B-12.65
Caris Life Sciences, Inc. (CAI)United States$9.119B47.87
RadNet, Inc. (RDNT)United States$5.611B-229.65
GRAIL, Inc. (GRAL)United States$5.591B-7.78
VERACYTE, INC. (VCYT)United States$3.904B41.21
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30